Edition:
United States

Thermo Fisher Scientific Inc (TMO.N)

TMO.N on New York Stock Exchange

240.20USD
2:08pm EST
Change (% chg)

$-1.07 (-0.44%)
Prev Close
$241.27
Open
$241.59
Day's High
$245.23
Day's Low
$239.92
Volume
123,660
Avg. Vol
402,701
52-wk High
$253.83
52-wk Low
$188.21

Latest Key Developments (Source: Significant Developments)

Thermo Fisher Considers Sale Of $1 Bln Pathology Unit-Bloomberg
Wednesday, 31 Oct 2018 04:28am EDT 

Oct 31 (Reuters) - :THERMO FISHER CONSIDERS SALE OF $1 BILLION PATHOLOGY UNIT-BLOOMBERG, CITING SOURCES.  Full Article

UK CMA Considering If Thermo Fisher-Roper Unit Deal Will Hurt Competition
Wednesday, 24 Oct 2018 10:06am EDT 

Oct 24 (Reuters) - UK CMA::UK CMA- CONSIDERING IF THERMO FISHER ACQUISITION OF ELECTRON MICROSCOPE PERIPHERALS BUSINESS OF ROPER WILL RESULT IN MERGER SITUATION CREATION.UK CMA- CONSIDERING IF THERMO FISHER-ROPER DEAL MAY RESULT IN LESSENING OF COMPETITION WITHIN ANY MARKET OR MARKETS IN UK FOR GOODS OR SERVICES.  Full Article

Thermo Fisher Scientific Reports Q3 EPS of $1.75
Wednesday, 24 Oct 2018 06:00am EDT 

Oct 24 (Reuters) - Thermo Fisher Scientific Inc ::THERMO FISHER SCIENTIFIC QTRLY REVENUE $5.92 BILLION VERSUS $5.12 BILLION.THERMO FISHER SCIENTIFIC - RAISES 2018 REVENUE GUIDANCE TO RANGE OF $23.99 BILLION TO $24.09 BILLION.THERMO FISHER SCIENTIFIC - RAISES 2018 ADJUSTED EPS GUIDANCE TO RANGE OF $11.00 TO $11.06.Q3 EARNINGS PER SHARE VIEW $2.55, REVENUE VIEW $5.70 BILLION -- THOMSON REUTERS I/B/E/S.THERMO FISHER SCIENTIFIC QTRLY EARNINGS PER SHARE $1.75; QTRLY ADJUSTED EARNINGS PER SHARE $2.62.FY2018 EARNINGS PER SHARE VIEW $10.99, REVENUE VIEW $23.86 BILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Thermo Fisher Scientific Board Authorizes $2 Billion Of Share Repurchases
Friday, 7 Sep 2018 09:00am EDT 

Sept 7 (Reuters) - Thermo Fisher Scientific Inc ::THERMO FISHER SCIENTIFIC BOARD AUTHORIZES $2 BILLION OF SHARE REPURCHASES.THERMO FISHER SCIENTIFIC INC - SHARE REPURCHASE AUTHORIZATION HAS NO EXPIRATION DATE.  Full Article

BD Statement On Divestiture Of Advanced Bioprocessing Business
Friday, 7 Sep 2018 06:01am EDT 

Sept 7 (Reuters) - Becton Dickinson and Co ::BD STATEMENT ON DIVESTITURE OF ADVANCED BIOPROCESSING BUSINESS.BECTON DICKINSON AND CO - EXPECTS TO RECORD A TAX GAIN ON TRANSACTION AT TIME OF CLOSING.BECTON DICKINSON - FOR FISCAL 2018, BD ESTIMATES CONTRIBUTION FROM ADVANCED BIOPROCESSING BUSINESS TO EPS OF ABOUT $0.13 TO $0.15 ON A FY BASIS.  Full Article

Thermo Fisher Scientific To Acquire Advanced Bioprocessing Business From BD
Friday, 7 Sep 2018 06:00am EDT 

Sept 7 (Reuters) - Thermo Fisher Scientific Inc ::THERMO FISHER SCIENTIFIC TO ACQUIRE ADVANCED BIOPROCESSING BUSINESS FROM BD.THERMO FISHER SCIENTIFIC INC - BD'S ADVANCED BIOPROCESSING BUSINESS WILL BE INTEGRATED INTO THERMO FISHER'S LIFE SCIENCES SOLUTIONS SEGMENT.  Full Article

Pluristem Signs Collaboration Agreement With Thermo Fisher Scientific
Monday, 9 Jul 2018 07:00am EDT 

July 9 (Reuters) - Pluristem Therapeutics Inc ::PLURISTEM SIGNS COLLABORATION AGREEMENT WITH THERMO FISHER SCIENTIFIC.PLURISTEM THERAPEUTICS - ENTERED STRATEGIC COLLABORATION WITH THERMO FISHER SCIENTIFIC TO ADVANCE KNOWLEDGE OF CELL THERAPY INDUSTRIALIZATION.  Full Article

Thermo Fisher Scientific Signs Deal With Benchsci
Monday, 9 Jul 2018 07:00am EDT 

July 9 (Reuters) - Thermo Fisher Scientific Inc ::THERMO FISHER SCIENTIFIC - SIGNED AN DEAL WITH BENCHSCI.  Full Article

Thermo Fisher Scientific Signs Agreement To Acquire Gatan From Roper Technologies
Thursday, 28 Jun 2018 04:05pm EDT 

June 28 (Reuters) - Roper Technologies Inc ::THERMO FISHER SCIENTIFIC SIGNS AGREEMENT TO ACQUIRE GATAN FROM ROPER TECHNOLOGIES.ROPER TECHNOLOGIES INC - THERMO FISHER WILL ACQUIRE GATAN, INC., A WHOLLY OWNED SUBSIDIARY OF ROPER, FOR APPROXIMATELY $925 MILLION IN CASH.  Full Article

Spectrum Pharmaceuticals Enters Into A Next-Generation Sequencing Companion Diagnostic Partnership With Thermo Fisher Scientific
Tuesday, 1 May 2018 07:00am EDT 

May 1 (Reuters) - Spectrum Pharmaceuticals Inc ::SPECTRUM PHARMACEUTICALS ENTERS INTO A NEXT-GENERATION SEQUENCING COMPANION DIAGNOSTIC PARTNERSHIP WITH THERMO FISHER SCIENTIFIC.SPECTRUM PHARMACEUTICALS INC - ENTERED INTO AN AGREEMENT WITH THERMO FISHER SCIENTIFIC.SPECTRUM PHARMACEUTICALS - AGREEMENT TO LEVERAGE ONCOMINE DX TARGET TEST AS COMPANION DIAGNOSTIC FOR SPECTRUM'S NOVEL PAN-HER INHIBITOR POZIOTINIB.  Full Article

Thermo Fisher raises forecast after third-quarter profit beat

Thermo Fisher Scientific Inc reported a better-than-expected quarterly profit on Wednesday on higher demand for its laboratory products and the world's largest scientific instruments maker raised its full-year forecast.